Bhutan vs Fiji: Previously treated cases tested for RR-/MDR-TB
Bhutan
100.0%
in 2024
Fiji
100.0%
in 2024
Bhutan rank
1st
Fiji rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bhutan
- Fiji
How they compare
Bhutan currently reports 100.0% against 100.0% in Fiji, a difference of 0.0%.
The two have swapped places 8 times across 16 shared years of data; in 2009 it was Fiji ahead.
Bhutan ranks 1st and Fiji ranks 1st of 180 countries.
Across the 3 decades both report, Bhutan averaged higher in 2 and Fiji in 1.
Head to head by decade
| Decade | Bhutan | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.0% | 100.0% | 89.0% | Fiji |
| 2010s | 48.5% | 48.1% | 0.3% | Bhutan |
| 2020s | 95.2% | 81.8% | 13.4% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bhutan or Fiji?
- Bhutan, at 100.0% against 100.0% in Fiji as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bhutan and Fiji?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Fiji?
- 16 years are reported by both, from 2009 to 2024.
- How do Bhutan and Fiji rank globally for previously treated cases tested for rr-/mdr-tb?
- Bhutan ranks 1st and Fiji ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.